NASDAQ:BLUE
bluebird bio Stock News
$0.97
-0.0354 (-3.50%)
At Close: May 08, 2024
Should Investors Buy the Dip With Bluebird Bio Stock?
10:15am, Thursday, 06'th Apr 2023
Bluebird Bio's stock is getting punished in the bear market. The business should start to bring in a lot more revenue soon.
What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio
08:00am, Thursday, 06'th Apr 2023
CRISPR Therapeutics and Bluebird Bio will soon likely compete for market share. CRISPR has plenty of money and a collaborator with deep pockets.
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
06:30am, Thursday, 06'th Apr 2023
Both Editas Medicine and Bluebird Bio are in a race against their cash runway. Editas is a lot further from commercializing any medicines.
bluebird bio: Decision Delays Add Further Pressure
01:17pm, Tuesday, 04'th Apr 2023
bluebird bio received a delay in the long-awaited FDA decision on sickle cell disease gene therapy. Approval would put them in a much stronger position for growth in this large market with a one-dose
1 Small-Cap Stock That Could Soar in 2023
09:15am, Sunday, 02'nd Apr 2023
Bluebird Bio will continue the launch of two newly commercialized therapies. The small-cap biotech is also seeking another key approval this year.
bluebird (BLUE) Down on Updates on SCD Therapy, Reports Q4
02:33pm, Friday, 31'st Mar 2023
bluebird (BLUE) provides updates on its BLA submission for its experimental gene therapy lovo-cel and reports Q4 results. Shares are down on the same.
Why Bluebird Bio Stock Is Sinking This Week
01:54pm, Thursday, 30'th Mar 2023
Bluebird Bio reported 2022 Q4 earnings on Wednesday. In the report, the biotech revealed that its experimental sickle cell disease therapy might experience a slight regulatory delay.
Bluebird Bio (BLUE) Reports Q4 Loss, Misses Revenue Estimates
09:59am, Wednesday, 29'th Mar 2023
Bluebird (BLUE) delivered earnings and revenue surprises of -26.67% and 99.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
1 Beaten-Down Stock That Has a Lot to Prove in 2023
08:05am, Wednesday, 08'th Feb 2023
This biotech looks like a high-risk, high-reward play.
3 Stocks to Keep an Eye on for Superb Earnings Acceleration
07:32am, Monday, 23'rd Jan 2023
Stocks like bluebird bio (BLUE), Pros Holdings (PRO), and Norwegian Cruise Line (NCLH) are worth a watch now because of solid earnings acceleration.
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
09:00am, Sunday, 22'nd Jan 2023
Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies.
bluebird (BLUE) Stock Dives on Public Offering of Common Stock
12:02pm, Thursday, 19'th Jan 2023
bluebird (BLUE) to issue secondary shares, diluting its current shareholder base. The company plans to raise $120 million in gross proceeds from this issue.
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
09:12am, Wednesday, 18'th Jan 2023
The Nasdaq looked poised for modest gains once again on Wednesday.
Why is Bluebird Bio (BLUE) Stock Down 9% Today?
08:54am, Wednesday, 18'th Jan 2023
Bluebird Bio (NASDAQ: BLUE ) stock is slipping on Wednesday after the biotechnology company announced a proposed public offering. The Bluebird Bio public stock offering includes 20 million shares of B
bluebird (BLUE) Updates on Progress With Zynteglo, 2023 Outlook
02:18pm, Tuesday, 10'th Jan 2023
bluebird bio, Inc. (BLUE) updates on the launch of gene therapy Zynteglo and provides cash burn guidance for 2023.
